1st Counsel – Lifestyle
Author:
Solid Biosciences Inc.
Solid Biosciences to Participate at Upcoming Investor Conferences
April 7, 2026
Solid Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
March 19, 2026
Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
March 11, 2026
Solid Biosciences to Present at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
March 6, 2026
Solid Biosciences Announces Oversubscribed $240 Million Private Placement
March 6, 2026